CVS Health Corp. (CVS) is expected to report earnings on Wednesday, November 4, 2026, before the open. Estimated release time 06:32 ET. Consensus EPS estimate is $1.61.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-05 | FY2026 Q2 | $1.87 | $2.33 | +24.6% | $106.10B |
| 2026-05-06 | FY2026 Q1 | $2.21 | $2.57 | +16.3% | $100.43B |
| 2026-02-10 | FY2025 Q4 | $1.00 | $1.09 | +9.0% | $105.69B |
| 2025-10-29 | FY2025 Q3 | $1.37 | $1.60 | +16.8% | $102.87B |
| 2025-07-31 | FY2025 Q2 | $1.46 | $1.81 | +24.0% | $98.92B |
| 2025-05-01 | FY2025 Q1 | $1.70 | $1.41 | -17.1% | $94.59B |
| 2025-02-12 | FY2024 Q4 | $0.91 | $1.19 | +30.2% | $97.71B |
| 2024-11-06 | FY2024 Q3 | $1.44 | $1.09 | -24.3% | $95.43B |
CVS has beaten consensus EPS in 6 of its last 8 reported quarters.
See CVS on the live calendar →